4//SEC Filing
Bevers Denise 4
Accession 0001250853-21-000039
CIK 0001561743other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:35 PM ET
Size
10.2 KB
Accession
0001250853-21-000039
Insider Transaction Report
Form 4
Bevers Denise
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-03-17$5.00/sh−8,396$41,997→ 0 total(indirect: By SD Scientific, Inc.) - Exercise/Conversion
Stock Option (right to buy)
2021-03-17−8,396→ 0 total(indirect: By SD Scientific, Inc.)Exercise: $0.32From: 2013-05-09Exp: 2023-05-09→ Common Stock (8,396 underlying) - Exercise/Conversion
Common Stock
2021-03-17$0.32/sh+8,396$2,687→ 8,396 total(indirect: By SD Scientific, Inc.)
Holdings
- 143,835
Common Stock
Footnotes (3)
- [F1]Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.015, inclusive. The Reporting Person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
Documents
Issuer
Kindred Biosciences, Inc.
CIK 0001561743
Entity typeother
Related Parties
1- filerCIK 0001593865
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:35 PM ET
- Size
- 10.2 KB